Published on
June 15, 2026
- 19:49 GMT
Hyfe Cough Monitoring Primary Endpoint in Pivotal Clinical Trial for First Digital Therapeutic to Treat Chronic Cough
For only the second time globally, wearable data has been accepted by a major regulator as the primary endpoint in a pivotal clinical trial. WILMINGTON, DE, UNITED STATES, June 15, 2026 /EINPresswire.com/ -- Hyfe, Inc., the global leader in continuous …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
